Refining strategies for the prevention and control of hypertension and related complications

Ethnicity & Disease
|December 22, 1999
PubMed

Insights

Despite advances in hypertension treatment, blood pressure control remains poor globally. New strategies are needed, emphasizing patient education, multidisciplinary care, and addressing socioeconomic barriers to improve hypertension management.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Health Policy

Background:

  • Hypertension is a primary preventable cause of premature death and disease, including heart disease, heart failure, stroke, and kidney failure.
  • Despite significant progress in antihypertensive medications and treatment guidelines, blood pressure control rates remain disappointingly low worldwide, affecting fewer than 25% of hypertensive individuals.

Discussion:

  • The 14th International Interdisciplinary Conference on Hypertension in Blacks (ISHIB99) convened to address the persistent challenge of suboptimal hypertension control.
  • Key discussion points focused on multifaceted strategies to improve hypertension treatment and control rates globally.

Key Insights:

  • Recommendations include enhanced patient and family health education, greater involvement of non-physician healthcare providers, and aggressive management of associated cardiovascular risk factors.
  • Improving access to quality care for underserved populations and fostering patient engagement in decision-making are crucial.
  • Addressing psychosocial factors and strengthening communication networks among healthcare providers and patients are vital for better outcomes.

Outlook:

  • A renewed commitment to community participation and partnerships with managed care and professional organizations is essential.
  • Implementing these comprehensive strategies can lead to improved blood pressure control and reduced hypertension-related morbidity and mortality.
  • Future efforts should focus on refining hypertension management through integrated, patient-centered, and accessible healthcare approaches.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...